Rosuvastatin recalls
The FDA has published 8 recalls involving Rosuvastatin since 2023. The latest was reported on 14 Jan 2026. Most were for manufacturing (cgmp) deviations. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls8since 2023
Last 12 months1reported
Class I00% of total
Ongoing4latest 14 Jan 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 100%Class III 0 0%
Why rosuvastatin is recalled
Companies
Brands
By year
Ongoing rosuvastatin recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Rosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatin | AvKARE | Potency & Assay | Nationwide |
| Drug | CLASS II | Rosuvastatin Tablets 40mg recalled by Glenmark PharmaceuticalsRosuvastatin Calcium | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) bottle recalled | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Rosuvastatin Tablets, USP, 5mg recalled by Preferred Pharmaceuticals | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
All rosuvastatin recalls, newest first
8 totalShould you stop taking Rosuvastatin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.